Skip to main navigation Skip to main content

Page translation not available

This page is not available in the language that has been selected and will appear in English.

Search

Contact us

07 3737 4500

PO Box 3787

South Brisbane QLD 4101

LIBERATE

Clinical registry of focal low dose rate brachytherapy in men with biopsy confirmed low-intermediate risk prostate cancer

Open for recruitment

Trial summary

This study aims to establish a clinical registry, encompassing patient data from men with prostate cancer undergoing focal LDR brachytherapy.

Enrolled participants will undergo a pre-plan volume study for the purpose of brachytherapy planning, followed by seed implantation 4-12 weeks later. Post-implantation, a non-contrast CT scan and/or MRI of the true pelvis will be acquired for the purpose of assessing implant quality and determining dose to organs at risk.

Trial details

Short title

LIBERATE

Diagnosis

Prostate cancer

Type of treatment

Radiation Oncology

Phase

N/A

Who can participate

Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.